Database for Interstitial Lung Disease

ConditionLung Diseases, Interstitial

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorMedical University of Graz

About this trial

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: ≥ 18 years

patients with a known systemic disease bearing a risk for ILD

signed informed consent (for prospective part)

Disqualifiers

Age < 18 years

comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Trial population

Patients (females and males; above 18 yrs) with a known systemic disease bearing a risk for ILD but without diagnosed ILD and patients (females and males; above 18 yrs) with diagnosed ILD.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

chest CT
Diagnostic test
assessment of interstitial lung disease using chest CT

Treatment groups

412 Participants

are divided into 2 treatment groups

Group A: prospective patient cohort1 intervention

Group B: retrospective patient cohort1 intervention

Trial outcomes

Primary outcomes

DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis

The investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis

Time frame

5 years

Secondary outcomes

FVC%pred (Forced vital capacity) at time of ILD diagnosis

The investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis

Time frame

5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medical University of Graz

Lead sponsor

Boehringer Ingelheim

Collaborator

Source ClinicalTrials.gov

Apply now